Advancing Ocular Device Delivery: Exploring Routes, Challenges, and Innovations to Meet Patient Needs
EducationalThe Optimal Primary Packaging for Biologics: Practical Application with PFS for Intravitreal Injections
2025-06-05 | 11:00 AM - 11:15 AM | TPD Room
Information
Advancing ocular device delivery has become a critical focus in addressing the increasing prevalence of ocular diseases and the demand for innovative treatments. Intravitreal injection, a procedure that administers medication directly into the vitreous cavity, has gained traction due to the growing availability of biopharmaceuticals and biosimilars. Prefilled syringes (PFS) are widely adopted in this context, offering notable benefits such as ease of use, reduced risk of endophthalmitis, and minimized overfill.
However, despite these advantages, challenges persist in achieving optimal ocular drug delivery. Concerns such as infection risks, dosing accuracy, and patient adherence remain significant hurdles. In response, alternative delivery routes are under exploration to enhance both therapeutic efficacy and patient convenience. Advances in nanotechnology, biodegradable polymers, and gene therapy further promise to revolutionize ocular treatments by reducing injection frequency and improving overall outcomes.
This presentation delves into the evolving landscape of ocular device delivery, examining key challenges, while also highlighting the latest technological innovations and regulatory considerations. By exploring these developments, we aim to chart a course toward more personalized and effective ocular therapies that better meet patient needs.
